Design and biological evaluation of novel antitumor agents with mechanisms of action against topoisomerase II and/or G-quadruplexesKim, Mu-yong. January 2002 (has links) (PDF)
Thesis (Ph. D.)--University of Texas at Austin, 2002. / Vita. Includes bibliographical references. Available also from UMI Company.
Wood, James Brent, 1942-
No description available.
Wiedhopf, Richard Michael, 1940-
No description available.
No description available.
Lin, Tung Yin,
(has links) (PDF)
Thesis (M.S.)--Eastern Illinois University, 2008. / Includes bibliographical references (leaves 66-68).
Pharmacological studies on the anti-neoplastic agent, 4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamideSkibba, Joseph Leo, January 1970 (has links)
Thesis (Ph. D.)--University of Wisconsin--Madison, 1970. / Typescript. Vita. eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references.
Metabolic and biochemical studies on the anti-neoplastic agent, 5-(3,3-dimethy-1-triazeno)-imidazole-4-carboxamideBeal, Diane Dorothy. January 1977 (has links)
Thesis--Wisconsin. / Vita. Includes bibliographical references.
Biochemical and cytological effects of the anticancer alkaloid, acronycine, on tumor cells in cultureDunn, Bruce Partridge January 1974 (has links)
Acronycine is an acridone alkaloid occurring in the bark of the Australian scrub ash. It has been reported to have considerable anti-tumor activity against a variety of experimental neoplasms, and is currently undergoing clinical trials. Little is known of the mechanisms responsible for its antitumor activity. The current study describes some of the cytological and biochemical effects of the alkaloid on tumor cells in culture. The growth in vitro of L5I78Y mouse and IRC rat leukemia cells was inhibited by acronycine at concentrations of 3 to 12 μ the incorporation of extracellular nucleosides into intracellular nucleic acid precursor pools - this effect appeared to account entirely for the inhibition of the incorporation of these precursors into nucleic acids. The mechanism by which L5I78Y cells utilize extracellular uridine and by which acronycine interferes with this process were studied. The results of investigations into the kinetics and temperature dependence of uridine uptake by whole cells and of uridine phosphorylation by cell extracts suggested that: (i) the transport of uridine across the plasma membrane is a step independent from its subsequent phosphorylation, and (ii) this transport is normally rate-limiting in the uptake of this nucleoside. Acronycine, at concentrations which markedly inhibited uridine uptake in whole cells, had little or no effect on the phosphorylation of uridine in cell extracts. This and other evidence (including the effect of acronycine on the temperature dependence and kinetics of uridine uptake) suggested that the inhibition by acronycine of the utilization by L5I78Y cells of extracellular uridine results from an interference with the transport of the nucleoside across the plasma membrane. A similar mechanism may also account for the inhibition of the uptake of other nucleosides, as well as for a slight inhibition of choline and inositol uptake which was also observed in this study. 14C-acronycine was prepared and shown to be bound rapidly and reversibly to L5I78Y cells. It was also bound to non-dialysable serum components, in which form it appeared to no longer be available for interaction with cells. This latter effect may have implications for the us of acronycine in chemotherapy. Most or all of the observed effects of acronycine can tentatively be explained on the basis of a akaloid-induced alterations in membrane function. Acronycine is a relatively water-insoluble, lipophilic compound, and as such may reasonably be expected to interact with lipids and/or hydrophobic regions of proteins. It is speculated that interactions of this type with membrane components may be responsible for the biological effects of this compound. / Medicine, Faculty of / Biochemistry and Molecular Biology, Department of / Graduate
Synthesis of protected amino thymidines and new thiol derivatives of the vascular targeting agent combretastatin A-4Ramirez, Daniel A. Kane, Robert R. January 2006 (has links)
Thesis (M.S.)--Baylor University, 2006. / Includes bibliographical references (p. 63-65).
Wan, Chung Tin. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2008. / Includes bibliographical references (leaves 126-139). / Abstracts in English and Chinese. / Thesis / Assessment Committee --- p.i / Acknowledgement --- p.ii / Abstract (English) --- p.iii / Abstract (Chinese) --- p.v / List of Abbreviations --- p.vii / List of Tables --- p.ix / List of Figures --- p.x / Chapter Chanter 1 --- Introduction / Chapter 1.1. --- Overview of cancer --- p.1 / Chapter 1.1.1 --- Breast cancer --- p.1 / Chapter 1.1.2 --- Hepatocellular carcinoma (HCC) --- p.2 / Chapter 1.2. --- Role of natural products in the fight against cancer --- p.3 / Chapter 1.2.1 --- Introduction of Astragalus membranaceus --- p.4 / Chapter 1.2.2 --- Introduction of Acanthopanax senticosus --- p.9 / Chapter 1.2.3 --- Introduction of Grifola Frondosa --- p.13 / Chapter 1.3. --- Apoptosis and cancer --- p.17 / Chapter 1.3.1 --- Caspases --- p.20 / Chapter 1.3.2 --- Intrinsic apoptotic pathway --- p.21 / Chapter 1.3.3 --- Extrinsic apoptotic pathway --- p.23 / Chapter 1.3.4 --- Execution of apoptosis --- p.26 / Chapter 1.4 --- Cell cycle and cancer --- p.27 / Chapter 1.5 --- Objective of this project: --- p.29 / Chapter Chapter 2 --- Materials and Methods / Chapter 2.1 --- Materials: --- p.30 / Chapter 2.1.1 --- Culture medium --- p.30 / Chapter 2.1.2 --- Buffers and reagents --- p.31 / Chapter 2.1.3 --- Herbs --- p.34 / Chapter 2.2 --- Methods --- p.35 / Chapter 2.2.1 --- Cell cultures --- p.35 / Chapter 18.104.22.168 --- Cell lines --- p.35 / Chapter 22.214.171.124 --- Cell culture techniques --- p.36 / Chapter 126.96.36.199 --- Cryopreservation of cell lines --- p.36 / Chapter 2.2.2 --- Proliferation assay --- p.37 / Chapter 188.8.131.52 --- MTT assay --- p.37 / Chapter 184.108.40.206 --- Isolation of PBMC --- p.38 / Chapter 220.127.116.11 --- XTT --- p.39 / Chapter 2.2.3 --- DNA fragmentation --- p.39 / Chapter 2.2.4 --- Flow cytometry --- p.41 / Chapter 18.104.22.168 --- Detection of mitochondrial membrane depolarization by the use of JC-1 --- p.41 / Chapter 22.214.171.124 --- Annexin-V-FITC PI labeling of apoptotic cells --- p.42 / Chapter 126.96.36.199 --- Cell cycle analysis --- p.43 / Chapter 2.2.5 --- Western blotting --- p.43 / Chapter 188.8.131.52 --- Total protein extraction --- p.44 / Chapter 184.108.40.206 --- Determining protein concentration --- p.44 / Chapter 220.127.116.11 --- SDS-PAGE --- p.45 / Chapter 18.104.22.168 --- Electroblotting --- p.45 / Chapter 22.214.171.124 --- Probing --- p.46 / Chapter 126.96.36.199 --- ECL --- p.46 / Chapter 2.2.6 --- Preparation of herbal extracts --- p.47 / Chapter 188.8.131.52 --- Preparation of extract of Astragalus membranaceus and Grifola frondosa --- p.47 / Chapter 184.108.40.206 --- Preparation of Acanthopanax senticosus aqueous extract --- p.47 / Chapter 220.127.116.11 --- Partition of Acanthopanax --- p.47 / Chapter 18.104.22.168 --- Column purification of ethyl-acetate fraction --- p.48 / Chapter 22.214.171.124 --- Analytical thin layer chromatography --- p.49 / Chapter 2.2.7 --- Statistical Analysis --- p.50 / Chapter Chanter 3 --- Results / Chapter 3.1 --- Extractions --- p.51 / Chapter 3.2 --- Anti-proliferative effect of herbal extracts on cancer cell lines --- p.51 / Chapter 3.3 --- Partition of Acanthopanax methanol extract --- p.56 / Chapter 3.4 --- Anti-proliferative effect of Acanthopanax partition fractions on breast cancer cells --- p.59 / Chapter 3.5 --- Column chromatography of ethyl acetate fraction --- p.59 / Chapter 3.6 --- Anti-proliferative effect of various sub-fractions on breast cancer cells --- p.64 / Chapter 3.7 --- Effect of sub-fractions on PBMC proliferation --- p.76 / Chapter 3.8 --- Kinetic study of anti-proliferative effect of Fc --- p.76 / Chapter 3.9 --- Flow cytometric analysis --- p.79 / Chapter 3.91 --- JC-1 staining --- p.79 / Chapter 3.92 --- Annexin-P1 labeling --- p.79 / Chapter 3.93 --- Cell cycle analysis --- p.80 / Chapter 3.10 --- DNA fragmentation assay --- p.88 / Chapter 3.11 --- Western blotting --- p.91 / Chapter Chanter 4 --- Discussion --- p.99 / Chapter Chapter 5 --- Conclusion --- p.124 / References --- p.126
Page generated in 0.1133 seconds